HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Balks At CIR Public-Private Partnership In FY 2017 Budget Request

This article was originally published in The Rose Sheet

Executive Summary

Based on its fiscal 2017 budget justification, FDA does not support a congressional proposal to formalize Cosmetic Ingredient Review safety assessments through a public-private partnership. The agency still intends to prepare a report on the subject, as directed by Senate and House appropriations committees, but characterizes the proposed framework as "inappropriate."

Advertisement

Related Content

FDA’s Holiday Gift To Cosmetics Industry: 10ppm Recommended Lead Cap
CIR Panel Plans For Lead Acetate Review At FDA’s Request
FDA Issues Second Warning This Year For Bentonite Clay Lead, Claims
FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill
FDA: Ingredient Safety Decisions Under PCPSA Could Differ From CIR
FDA Status Updates On Citizen Petitions Would Not Signal Decision Pending
PCPSA's 'No Harm' Standard Would Set High Bar For FDA Ingredient Review
Congress Proposes Public-Private Partnership For CIR
FDA Will Respond To Lipstick Lead-Limit Petition In March
FDA Issues Final Lead-In-Lipstick Report, Postpones Decision On Cosmetic Lead Limits

Topics

Advertisement
UsernamePublicRestriction

Register

RS020003

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel